Home / Publication / Pharmacokinetics and Safety of Oseltamivir in Patients with End-stage Renal Disease Treated with Automated Peritoneal Dialysis

論文

Pharmacokinetics and Safety of Oseltamivir in Patients with End-stage Renal Disease Treated with Automated Peritoneal Dialysis

Author(s): Kashyap Patel, Craig Rayner, Mylène Giraudon, Mohamed Kamal, Peter Morcos, Richard Robson, Carl Kirkpatrick

Year: 2015年3月25日

AUC（線形および対数線形）の計算

ブログ

Accumulation: What It Means and How to Calculate It

ブログ

Blending Science & Impact in Drug Development: Felix Boakye-Agyeman, Vice President of the QSS Division at Certara

ビデオ

Bridging Strategy & Execution: Sophia Fong’s Approach to Drug Development

ビデオ

Powered by Translations.com GlobalLink Web Software

Pharmacokinetics and Safety of Oseltamivir in Patients with End-stage Renal Disease Treated with Automated Peritoneal Dialysis

Pharmacokinetics and Safety of Oseltamivir in Patients with End-stage Renal Disease Treated with Automated Peritoneal Dialysis

AUC（線形および対数線形）の計算

Accumulation: What It Means and How to Calculate It

Blending Science & Impact in Drug Development: Felix Boakye-Agyeman, Vice President of the QSS Division at Certara

Bridging Strategy & Execution: Sophia Fong’s Approach to Drug Development

メルマガ登録

クイックアクセス

ソリューション

お問合せ